More and more, as momentum builds for the soon-to-be-blockbuster Winrevair, Merck’s $11.5 billion buyout of Acceleron in 2021 is looking like a savvy move. | Paving the way for the label update were ...

The push for a label change came after President Donald Trump held a news conference last month in which he told pregnant ...

The FDA enlisted British drugmaker GSK to help it fast-track approval of leucovorin to treat an autism-related disorder.

While most over-the-counter pain relievers are not recommended for use during pregnancy, acetaminophen is backed by decades' ...

Eli Lilly announced on Friday safety and efficacy results from two separate late-stage studies testing its approved drugs for ...

Positive data from Phase 2 MaGic trial presented for claseprubart in generalized Myasthenia Gravis, including new open-label extension data ...

The Phase 3 ADAPT SERON study met its primary endpoint (p-value=0.0068), demonstrating that AChR-Ab seronegative gMG patients treated with VYVGART achieved a statistically significant improvement in ...

Two oral presentations to highlight biomarker, imaging and quality-of-life data from the open-label compensated MASH cirrhosis (F4c) arm of the ...

Supplements, especially in pill form, usually contain some type of bulking agent or filler to help achieve a uniform shape ...

A new study by the Hebrew University has developed a rapid imaging method that reveals how drugs move through the skin, in ...